METABOLIC AND CLINICAL EFFECTS OF GLIBENCLAMIDE
- 10 January 1970
- journal article
- Published by Elsevier in The Lancet
- Vol. 295 (7637) , 57-61
- https://doi.org/10.1016/s0140-6736(70)91844-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Glybenclamid (HB 419): ein neues orales Antidiabetikum der Sulfonylharnstoff-ReiheDeutsche Medizinische Wochenschrift (1946), 1969
- Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamideDiabetologia, 1969
- Glucose Content of Normal UrineBMJ, 1965
- Immunoassay of Serum Growth Hormone in Acromegalic PatientsBMJ, 1964
- Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic RatsDiabetes, 1963
- A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasmaJournal of Clinical Pathology, 1962
- Observations on an enzymic method for the estimation of pyruvate in bloodClinica Chimica Acta; International Journal of Clinical Chemistry, 1962
- Rapid Colorimetric Micro-method for Estimating Glucose in Blood and C.S.F. Using Glucose OxidaseBMJ, 1957